Coronavirus Resource Hub

Rethinking cancer clinical trials for COVID-19 and beyond
By Nature Research 14 June 2020
covid 19 cancer trials

The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential to ensure the resilience of clinical cancer research and optimize patient-centered care.

This article published in Nature Research presents potential solutions for sponsors, investigators and regulatory agencies both for ongoing trials during the pandemic and to aid the design and implementation of future trials.

Go to the article